PL1791530T3 - Kompozycja farmaceutyczna zawierająca psychostymulant - Google Patents

Kompozycja farmaceutyczna zawierająca psychostymulant

Info

Publication number: PL1791530T3
Authority: PL; Poland
Prior art keywords: psychostimulant; pharmaceutical composition; containing pharmaceutical; composition; psychostimulant containing
Prior art date: 2004-08-23

Application number

PL05775957T

Other languages

English (en)

Inventor

Reiner Poestges

Bernd Schneider

Richard Ammer

Original Assignee

Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-23

Filing date

2005-08-23

Publication date

2009-01-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35850133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1791530(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-08-23 Application filed by Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co Kg filed Critical Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co Kg

2009-01-30 Publication of PL1791530T3 publication Critical patent/PL1791530T3/pl

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
239000003368 psychostimulant agent Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL05775957T 2004-08-23 2005-08-23 Kompozycja farmaceutyczna zawierająca psychostymulant PL1791530T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP04019984		2004-08-23
EP04023039		2004-09-28
EP05775957A EP1791530B1 (en)	2004-08-23	2005-08-23	Psychostimulant containing pharmaceutical composition
PCT/EP2005/009106 WO2006021426A2 (en)	2004-08-23	2005-08-23	Psychostimulant containing pharmaceutical composition

Publications (1)

Publication Number	Publication Date
PL1791530T3 true PL1791530T3 (pl)	2009-01-30

Family

ID=35850133

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05775957T PL1791530T3 (pl)	2004-08-23	2005-08-23	Kompozycja farmaceutyczna zawierająca psychostymulant

Country Status (9)

Country	Link
US (1)	US8580301B2 (pl)
EP (2)	EP2036546B1 (pl)
AU (1)	AU2005276554B2 (pl)
CA (1)	CA2617941C (pl)
DE (1)	DE202005020881U1 (pl)
DK (2)	DK2036546T3 (pl)
ES (2)	ES2703874T3 (pl)
PL (1)	PL1791530T3 (pl)
WO (1)	WO2006021426A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2036546T3 (en)	2004-08-23	2018-12-17	Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co Kg	Psychostimulants containing a pharmaceutical composition
CA2645855C (en)	2006-03-16	2015-02-03	Tris Pharma, Inc.	Modified release formulations containing drug-ion exchange resin complexes
MX2011001384A (es)	2008-08-06	2011-09-27	Gosforth Ct Holdings Pty Ltd	Composiciones y metodos para tratar trastornos psiquiatricos.
US8840934B2 (en)	2009-01-02	2014-09-23	Rainbow Pharmaceutical Sa	Uses of ammonium chloride
US8287903B2 (en) *	2011-02-15	2012-10-16	Tris Pharma Inc	Orally effective methylphenidate extended release powder and aqueous suspension product
GB201111712D0 (en)	2011-07-08	2011-08-24	Gosforth Ct Holdings Pty Ltd	Pharmaceutical compositions
CA2880456A1 (en)	2012-08-15	2014-02-20	Tris Pharma, Inc.	Methylphenidate extended release chewable tablet
US11590228B1 (en)	2015-09-08	2023-02-28	Tris Pharma, Inc	Extended release amphetamine compositions
US12458592B1 (en)	2017-09-24	2025-11-04	Tris Pharma, Inc.	Extended release amphetamine tablets
US11590081B1 (en)	2017-09-24	2023-02-28	Tris Pharma, Inc	Extended release amphetamine tablets

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1201136B (it)	1987-01-13	1989-01-27	Resa Farma	Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
AU702801B2 (en)	1995-07-14	1999-03-04	Darwin Discovery Limited	Therapeutic use of D-threo-methylphenidate
US5922736A (en)	1995-12-04	1999-07-13	Celegene Corporation	Chronic, bolus administration of D-threo methylphenidate
US5837284A (en) *	1995-12-04	1998-11-17	Mehta; Atul M.	Delivery of multiple doses of medications
CA2264852C (en)	1996-09-30	2005-11-01	Alza Corporation	Use of methylphenidate or a pharmaceutically acceptable salt thereof
MXPA01004381A (es) *	1998-11-02	2005-09-08	Elan Corp Plc	Composicion de multiparticulado de liberacion modificada.
US6673367B1 (en) *	1998-12-17	2004-01-06	Euro-Celtique, S.A.	Controlled/modified release oral methylphenidate formulations
US6419960B1 (en) *	1998-12-17	2002-07-16	Euro-Celtique S.A.	Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
WO2000059479A1 (en) *	1999-04-06	2000-10-12	Pharmaquest Ltd.	Pharmaceutical dosage form for pulsatile delivery of methylphenidate
US20030170181A1 (en) *	1999-04-06	2003-09-11	Midha Kamal K.	Method for preventing abuse of methylphenidate
US6420473B1 (en)	2000-02-10	2002-07-16	Bpsi Holdings, Inc.	Acrylic enteric coating compositions
DK2036546T3 (en)	2004-08-23	2018-12-17	Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co Kg	Psychostimulants containing a pharmaceutical composition

2005
- 2005-08-23 DK DK08162152.6T patent/DK2036546T3/en active
- 2005-08-23 DK DK05775957T patent/DK1791530T3/da active
- 2005-08-23 CA CA2617941A patent/CA2617941C/en not_active Expired - Lifetime
- 2005-08-23 WO PCT/EP2005/009106 patent/WO2006021426A2/en not_active Ceased
- 2005-08-23 EP EP08162152.6A patent/EP2036546B1/en not_active Revoked
- 2005-08-23 DE DE202005020881U patent/DE202005020881U1/de not_active Expired - Lifetime
- 2005-08-23 PL PL05775957T patent/PL1791530T3/pl unknown
- 2005-08-23 EP EP05775957A patent/EP1791530B1/en not_active Expired - Lifetime
- 2005-08-23 AU AU2005276554A patent/AU2005276554B2/en not_active Expired
- 2005-08-23 ES ES08162152T patent/ES2703874T3/es not_active Expired - Lifetime
- 2005-08-23 ES ES05775957T patent/ES2314693T3/es not_active Expired - Lifetime
2007
- 2007-02-23 US US11/710,170 patent/US8580301B2/en active Active

Also Published As

Publication number	Publication date
ES2703874T3 (es)	2019-03-12
US20080075769A1 (en)	2008-03-27
CA2617941A1 (en)	2006-03-02
US8580301B2 (en)	2013-11-12
DE202005020881U1 (de)	2006-12-07
EP1791530A2 (en)	2007-06-06
EP2036546A1 (en)	2009-03-18
ES2314693T3 (es)	2009-03-16
CA2617941C (en)	2012-07-24
EP1791530B1 (en)	2008-08-13
DK2036546T3 (en)	2018-12-17
WO2006021426A2 (en)	2006-03-02
WO2006021426A3 (en)	2006-05-26
AU2005276554A1 (en)	2006-03-02
DK1791530T3 (da)	2008-10-27
AU2005276554B2 (en)	2011-08-25
EP2036546B1 (en)	2018-10-10

Publication	Publication Date	Title
IL177480A0 (en)	2006-12-10	Pharmaceutical composition
IL223545A0 (en)	2013-02-03	Pharmaceutical compositions
IL179809A0 (en)	2007-05-15	Pharmaceutical compositions
GB0408308D0 (en)	2004-05-19	Pharmaceutical compositions
EP1729744A4 (en)	2012-10-31	PHARMACEUTICAL PREPARATIONS
GB0426301D0 (en)	2004-12-29	Pharmaceutical formulations
IL183986A0 (en)	2007-10-31	Pharmaceutical compounds and compositions
ZA200705131B (en)	2008-06-25	Solid pharmaceutical composition comprising valsartan
SI2033629T1 (sl)	2013-01-31	Trden farmacevtski sestavek, ki obsega valsartan
PL1837019T3 (pl)	2013-02-28	Kompozycja farmaceutyczna rozpadająca się w ustach
GB0416397D0 (en)	2004-08-25	Pharmaceutical formulations
HU0401177D0 (en)	2004-08-30	Pharmaceutical composition
PL1791530T3 (pl)	2009-01-30	Kompozycja farmaceutyczna zawierająca psychostymulant
GB2411355B (en)	2006-02-22	Pharmaceutical composition
EP1805154A4 (en)	2009-11-25	PHARMACEUTICAL COMPOSITIONS
GB0425255D0 (en)	2004-12-15	Pharmaceutical composition
ZA200701932B (en)	2008-08-27	Pharmaceutical composition
IL180316A0 (en)	2007-07-04	Quinolone-containing medicinal composition
ZA200701931B (en)	2008-10-29	Pharmaceutical composition
GB0407351D0 (en)	2004-05-05	Pharmaceutical compositions
GB0400971D0 (en)	2004-02-18	Pharmaceutical compositions
ZA200702400B (en)	2008-09-25	Psychostimulant containing pharmaceutical composition
GB0422582D0 (en)	2004-11-10	Pharmaceutical compositions
GB0411502D0 (en)	2004-06-23	Pharmaceutical compositions
GB0402799D0 (en)	2004-03-10	Pharmaceutical composition